-
The Danish Medicines Agency will be closed on 22 May 2020
| 18 May 2020 |
The Danish Medicines Agency will be closed on 22 May 2020, the day after Ascension Day. However, we process urgent applications for compassionate use permits (applications for dispensing of non-marketed medicines manufactured by pharmaceutical companies).
-
Compassionate use permit for Remdesivir
| 05 May 2020 |
The Danish Medicines Agency would like to inform you that it is possible to apply for a general compassionate use permit for Remdesivir for the treatment of COVID-19 patients who cannot be included in one of the protocol-based clinical trials that are currently being conducted in Denmark.
-
COVID-19: Facts about chloroquine and hydroxychloroquine
| 07 April 2020 |
There are many rumours that hydroxychloroquine or chloroquine has a documented effect on COVID-19 and that other countries have approved it for COVID-19.
-
COVID-19: See the list of approved Danish clinical trials of medicines for COVID-19
| 07 April 2020 |
The Danish Medicines Agency has approved the first applications for clinical trials of medicines for COVID-19. A list on the Danish Medicines Agency’s website keeps you updated on approved applications.
-
Danish Medicines Agency has assessed and sent out replies for an exceptionally high number of clinical trial applications in March
| 06 April 2020 |
The Danish Medicines Agency has been extremely busy lately with the assessment of applications for clinical trials – not only COVID-19-related applications, but also applications for clinical trials of other medicines. All applications have been assessed, and all applicants have received a timely reply.
-
Follow worldwide studies and research on medicines for COVID-19
| 03 April 2020 |
The Danish Medicines Agency has formed a COVID-19 group that will continuously update a public list of worldwide studies and research on medicines for COVID-19.
-
EMA clarifies use of chloroquine and hydroxychloroquine for COVID-19
| 02 April 2020 |
Chloroquine and hydroxychloroquine must only be used for COVID-19 in clinical trials or national emergency use programmes in COVID-19 patients whose condition is critical, says the European Medicines Agency, EMA.
-
Clarification on companies’ notification of supply problems to the Danish Medicines Agency
| 01 April 2020 |
The Danish Medicines Agency would like to clarify when and how companies must notify the Danish Medicines Agency of any supply problems they might experience.
-
No evidence confirms reports that blood pressure medicines could worsen COVID-19
| 30 March 2020 |
After several specialist media and patient organisations in Denmark have disproved reports that ACE inhibitors and angiotensin receptor blockers could worsen the condition of COVID-19 patients, the European Medicines Agency now sends the same message.
-
Danish Medicines Agency initiates COVID-19 data analyses
| 27 March 2020 |
What is the drug consumption and medical history of Danish COVID-19 patients? And does the use of certain painkillers, including ibuprofen, affect the disease course of COVID-19?
-
Inquiries to the Danish Medicines Agency about medicines
| 27 March 2020 |
It is important to us that companies and industry associations feel they receive a prompt reply when they contact the Danish Medicines Agency.
-
More than 1,000 have responded to the Denmark helps Denmark campaign
| 27 March 2020 |
This weekend the Danish Medicines Agency launched the Denmark helps Denmark campaign wherein companies and manufacturers can make contributions to increase the supply of protective equipment like facemasks, gloves and shields for frontline staff. Thursday the number of responses exceeded 1,000.
-
COVID-19: Danish Medicines Agency puts inspection and control tasks on hold
| 26 March 2020 |
Due to the COVID-19 pandemic, the Danish Medicines Agency is putting all on-site inspections and laboratory controls on hold until further notice. The Danish Medicines Agency will, however, continue with office-based assessments and controls, and, if needed, also on-site inspections.
-
COVID-19: Watch out for illegal online sale
| 26 March 2020 |
Unauthorised retailers are illegally selling medicines and self-test kits online by exploiting fears and concerns amid the COVID-19 pandemic. “Extremely unsympathetic and dangerous to people’s lives and well-being,” says the Danish Medicines Agency’s Director General.
-
Paracetamol for children now only available from pharmacies
| 25 March 2020 |
Due to problems of supplying paracetamol for children, the Danish Medicines Agency is now taking action to ensure that there is enough for the children who need it the most. Director General of the Danish Medicines Agency: ”Buy only what you need”.
-
Danish Medicines Agency given more powers to counteract supply problems
| 24 March 2020 |
New rules have come into force, which means that companies, regions and municipalities may be ordered to report their supplies of medicines and medical devices to the Danish Medicines Agency, and that medicines and devices can be reallocated to areas in the healthcare service that need them the most.
-
COVID-19 and production of protective equipment: Collaboration between Danish Medicines Agency and Danish companies
| 24 March 2020 |
The Medicoindustrien, the Confederation of Danish Industry and the Danish Medicines Agency have formed a new collaboration to switch the production to gloves, lab coats, mouth shields, isolation gowns, masks and hand sanitizer.
-
New campaign to prevent shortage of protective equipment: Denmark helps Denmark
| 23 March 2020 |
The healthcare services are running short of protective equipment such as face masks and visors in many areas of Denmark. The Danish Medicines Agency now launches the “Denmark helps Denmark” campaign, urging authorities, companies and others to report it if they have excess equipment or ideas on how to procure more.
-
Risk of supply failure: Use protective equipment rationally
| 22 March 2020 |
There is a risk that the healthcare sector will run out of protective equipment, such as hand sanitizer, facemasks and visors/shields, which are crucial in the fight against coronavirus. We urge everyone to use at little as possible without compromising on safety.
-
Global action against illicit medicines and medical devices
| 20 March 2020 |
The global action Operation Pangea targeting the illicit sale of medicines and medical devices has now finished, and the results have been established. 635 parcels containing illegally imported medicines were seized in Denmark.
